Heart Disease News and Research

Latest Heart Disease News and Research

Study evaluates potential risks and benefits of moderate alcohol consumption

A discussion by renowned epidemiologist Kenneth Mukamal has recently been published in the Journal of the American Medical Association, JAMA. It provides a discussion in response to a theoretical question, - if you are a 42 year old male, should you drink alcohol ( in moderation) for your health?

30 Jun 2010

Seventh Annual HealthGrades Maternity Care in Hospitals Study ranks Good Samaritan in top 5%

Good Samaritan Hospital's maternity care is in the top 5 percent in the nation for the third year in a row according to a new study issued today by HealthGrades, Inc., the independent ratings organization. The Seventh Annual HealthGrades Maternity Care in Hospitals Study used state-government data to compare hospitals in terms of complication rates for vaginal and C-section deliveries as well as neonatal mortality.

30 Jun 2010

News round up: UniCare will drop health coverage for Virginians; Hawaii concerned about lack of physicians

The Washington Post: "About 3,000 Virginians who have health insurance through UniCare, a private insurer, will lose that coverage Jan. 1, a UniCare spokesman said Monday. Most live in Northern Virginia and get their coverage through the individual market, officials said.

30 Jun 2010

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

30 Jun 2010

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

Wishard Health Services, the nation's third-largest safety net health care system in outpatient visits, and the Regenstrief Institute Inc., an internationally-respected medical and public health informatics innovator, earned the NAPH 2010 President's Award for Health Reform Readiness and Leadership.

30 Jun 2010

Cardio3 BioSciences reports positive data from C-Cure stem cell therapy clinical trial for heart failure

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular diseases, today announces positive safety data and preliminary efficacy results from its clinical trial of C-Cure(R), a breakthrough stem cell therapy for heart failure.

30 Jun 2010

COBRA, jobs bill in further jeopardy after death of Sen. Byrd

Roll Call: The death of Sen. Robert Byrd, D-W. Va., has jeopardized further the passage of some bills in Congress, including a bill that would extend unemployment benefits. "Democratic leaders have been thwarted numerous times in recent weeks on jobs legislation, despite scaling down the measure dramatically after Republicans and some moderate Democrats balked at adding to the deficit.

30 Jun 2010

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

BSP, which develops and commercializes advanced products for the non invasive, accurate diagnosis of heart diseases, announced today that its Add-On product, the HyperQ AD-100, intended for improved diagnostic performance of Stress ECG, has been granted the European CE conformance mark.

30 Jun 2010

Importance of cell-cell communication in ischaemia

A team from the Bristol Heart Institute have investigated the importance of cell-cell communication in regulating the formation of new blood vessels following the restriction in blood supply to the heart or back leg in mice.

29 Jun 2010

USPTO grants Vermillion Alzheimer's disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.

29 Jun 2010

Siemens Radiation Reduction Alliance launched

In a continual commitment to patient care and radiation reduction in computed tomography (CT), Siemens Healthcare has launched SIERRA (Siemens Radiation Reduction Alliance) and has established an expert panel to advance the cause of dose reduction in CT. The new Low Dose Expert Panel includes 15 specialists in radiology, cardiology and physics, who are internationally recognized for their publications on the subject of CT dose.

29 Jun 2010

Claros point-of-care system for PSA receives European CE Mark approval

Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.

29 Jun 2010

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.

29 Jun 2010

BBD reports analyze effectiveness and safety of statin use

A series of new reports from Consumer Reports Best Buy Drugs (BBD) caution that the benefits of statin use by children and some women may not outweigh the risks. Drugs to lower cholesterol - including statins - are the most commonly prescribed drugs in the U.S. and garnered more than $14 billion in sales last year.

29 Jun 2010

Chelsea initiates NORTHERA Phase III trial for symptomatic NOH associated with PD

Chelsea Therapeutics International, Ltd. announced the initiation of Study 306, a pivotal Phase III trial evaluating the efficacy of NORTHERA™, an oral synthetic precursor of norepinephrine, for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with Parkinson's disease.

29 Jun 2010

Vitae earns $14M milestone payment from Boehringer Ingelheim

Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.

29 Jun 2010

First Edition: June 29, 2010

In this Kaiser Health News consumer column, Michelle Andrews writes: "Sarah Rose Nordgren works 25 to 30 hours a week as a waitress at an upscale restaurant in Chapel Hill, N.C. She also tutors high- schoolers on their college entrance essays and has an editorial internship at a book publisher. But if something were to go seriously wrong with her health, she'd be in trouble because none of her three jobs offers health insurance" (Kaiser Health News).

29 Jun 2010

Rosiglitazone therapy associated with increased risk for heart attack: Study

Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Jun 2010

Statins does not reduce death risk in high-risk individuals without heart disease

A meta-analysis of previously published studies finds no evidence that statins are associated with a reduced risk of death among individuals at risk for but with no history of cardiovascular disease, according to a report in the June 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals

29 Jun 2010

Phytonutrient-based medical food and heart-healthy diet reduce CVD risk factors: Study

New research presented at the American Diabetes Association's 70th Scientific Sessions in Orlando, Florida on June 27, 2010 suggests that a medical food developed by Metagenics, Inc. called UltraMeal® PLUS 360° enhances the cardiovascular disease (CVD) risk-lowering benefits of a Mediterranean-style low-glycemic-load diet.

29 Jun 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Study evaluates potential risks and benefits of moderate alcohol consumption

Seventh Annual HealthGrades Maternity Care in Hospitals Study ranks Good Samaritan in top 5%

News round up: UniCare will drop health coverage for Virginians; Hawaii concerned about lack of physicians

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

Cardio3 BioSciences reports positive data from C-Cure stem cell therapy clinical trial for heart failure

COBRA, jobs bill in further jeopardy after death of Sen. Byrd

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

Importance of cell-cell communication in ischaemia

USPTO grants Vermillion Alzheimer's disease biomarker patent

Siemens Radiation Reduction Alliance launched

Claros point-of-care system for PSA receives European CE Mark approval

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

BBD reports analyze effectiveness and safety of statin use

Chelsea initiates NORTHERA Phase III trial for symptomatic NOH associated with PD

Vitae earns $14M milestone payment from Boehringer Ingelheim

First Edition: June 29, 2010

Rosiglitazone therapy associated with increased risk for heart attack: Study

Statins does not reduce death risk in high-risk individuals without heart disease

Phytonutrient-based medical food and heart-healthy diet reduce CVD risk factors: Study

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Heart Disease News and Research

Latest Heart Disease News and Research

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in